Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 9:15:1417896.
doi: 10.3389/fendo.2024.1417896. eCollection 2024.

Primary ovarian insufficiency consequence of autoimmune diseases: a bidirectional two-sample Mendelian randomization study

Affiliations

Primary ovarian insufficiency consequence of autoimmune diseases: a bidirectional two-sample Mendelian randomization study

Yongming Du et al. Front Endocrinol (Lausanne). .

Abstract

Background: Observational studies suggest the risk of primary ovarian insufficiency (POI) is increased in autoimmune disorders (AIDs), but it is unclear whether there is a causal relationship. Therefore, we aimed to investigate the bidirectional causality between 20 AIDs and POI using Mendelian randomization (MR) analysis.

Methods: A bidirectional two-sample MR investigation was designed by using publicly accessible summary-level data from genome-wide association studies (GWAS). The inverse variance weighted (IVW) method was performed as the main analysis, supplemented by several sensitivity analyses. Cochran Q test was used to evaluate SNP estimate heterogeneity. MR-Egger and MR-PRESSO methods were utilized to detect horizontal pleiotropy.

Results: The MR analyses revealed that genetically determined coeliac disease (CeD) (OR = 1.124, 95% CI 1.033-1.224, P = 0.007), vitiligo (OR = 1.092, 95% CI 1.003-1.188; P = 0.042), systemic lupus erythematosus (SLE) (OR = 1.122, 95% CI 1.030-1.223, P = 0.008), and selective immunoglobulin A deficiency (SIgAD) (OR = 0.866, 95% CI: 0.776-0.967, P = 0.011) exhibited significant causal relationships with POI. We also found suggestive evidence of positive effect of Addison's disease (AD) towards POI (OR5e-6 = 1.076, 95% CI 1.002-1.154, P = 0.043).

Conclusion: This comprehensive MR analysis indicated that SLE, CeD, vitiligo, and AD caused an increased risk of POI, SIgAD was associated with a decreased risk of POI. These insights carry profound clinical implications, particularly emphasizing the early intervention for women with AIDs/POI who wish to preserve their reproductive potential or plan for future pregnancies.

Keywords: Mendelian randomization; autoimmune disease; causal association; primary ovarian insufficiency; single-nucleotide polymorphisms.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Overview of the bidirectional two-sample MR analysis. Assumption 1: genetic instrumental variables are strongly related to the exposure; Assumption 2: genetic instrumental variables are independent from confounding factors of the exposure-outcome; Assumption 3: genetic instrumental variables influence outcomes solely through the exposure. SNPs, single nucleotide polymorphisms; POI, primary ovarian insufficiency; LD, linkage disequilibrium.
Figure 2
Figure 2
Forest plot illustrating the causal effect of autoimmune diseases on primary ovarian insufficiency. The causal effect of different autoimmune diseases on primary ovarian insufficiency was expressed as OR per unit. Error bars represent the 95% CIs of the estimates. GI, gastrointestinal; SNPs, single nucleotide polymorphisms; OR, odds ratio; CI, confidence interval.
Figure 3
Figure 3
Forest plot illustrating the associations of the genetically predicted primary ovarian insufficiency with the risk of autoimmune diseases. The causal effect of primary ovarian insufficiency on different autoimmune diseases was expressed as OR per unit. Error bars represent the 95% CIs of the estimates. GI, gastrointestinal; OR, odds ratio; CI, confidence interval.

Similar articles

References

    1. Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, et al. . Eshre Guideline: management of women with premature ovarian insufficiency. Hum Reprod. (2016) 31:926–37. doi: 10.1093/humrep/dew027 - DOI - PubMed
    1. Golezar S, Ramezani Tehrani F, Khazaei S, Ebadi A, Keshavarz Z. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric. (2019) 22:403–11. doi: 10.1080/13697137.2019.1574738 - DOI - PubMed
    1. Lagergren K, Hammar M, Nedstrand E, Bladh M, Sydsjö G. The prevalence of primary ovarian insufficiency in Sweden; a national register study. BMC Womens Health. (2018) 18:175. doi: 10.1186/s12905-018-0665-2 - DOI - PMC - PubMed
    1. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod. (2003) 18:199–206. doi: 10.1093/humrep/deg005 - DOI - PubMed
    1. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. (1986) 67:604–6. - PubMed

MeSH terms

LinkOut - more resources